SPBC13E7.07 Antibody

What is SPBC13E7.07 and what cellular functions is it associated with?

SPBC13E7.07 is a Schizosaccharomyces-specific protein found in fission yeast. Based on current research, it appears to be part of the nuclear envelope protein network, potentially interacting with proteins like Lem2 and Bqt4 which are involved in nuclear envelope organization and function . The protein has been identified in studies examining nuclear envelope protein interactions in Schizosaccharomyces pombe, suggesting its potential role in nuclear integrity and organization.

How does SPBC13E7.07 relate to nuclear envelope proteins like Lem2?

While direct interaction evidence is limited in the provided research data, SPBC13E7.07 appears in the context of studies examining Lem2, which is retained at the nuclear envelope through interaction with Bqt4 in fission yeast . Experimental approaches using immunoprecipitation (IP) with FLAG-Lem2-HA have been utilized to identify Lem2-binding proteins, which may include SPBC13E7.07 as part of this protein network. The relationship suggests potential functional associations in nuclear envelope organization or maintenance.

What are the recommended approaches for generating antibodies against SPBC13E7.07?

For generating antibodies against SPBC13E7.07, researchers should consider:

• Recombinant protein expression: Express the full-length or immunogenic fragments of SPBC13E7.07 in appropriate expression systems

• Custom antibody development: Either monoclonal or polyclonal antibodies can be developed depending on research needs

• Host selection: Consider rabbits for polyclonal antibodies or mice/rats for monoclonal development

• Validation strategy: Plan for validation using knockout strains or tagged versions of SPBC13E7.07

The development process should include careful epitope selection based on structural predictions and antigenicity analysis to ensure specificity for this Schizosaccharomyces-specific protein.

What validation methods should be employed to confirm SPBC13E7.07 antibody specificity?

To validate SPBC13E7.07 antibody specificity, implement a multi-tiered approach:

• Western blot analysis using wild-type vs. SPBC13E7.07 deletion mutants

• Immunoprecipitation followed by mass spectrometry (MS) to confirm antibody pulls down the target protein

• Immunofluorescence comparing staining patterns in wild-type vs. knockout strains

• Pre-adsorption tests with recombinant SPBC13E7.07 protein

• Cross-reactivity assessment against related proteins

Importantly, immunofluorescence protocol optimization should include proper fixation with 4% paraformaldehyde solubilized in 0.1% Triton X-100-PBS for 20 minutes at room temperature, followed by appropriate blocking and antibody incubation steps .

What is the optimal protocol for using SPBC13E7.07 antibody in immunofluorescence studies of fission yeast?

Optimized Immunofluorescence Protocol for SPBC13E7.07 in Fission Yeast:

• Grow S. pombe cells on coverslips in appropriate media to 50% confluence

• Wash cells twice with PBS to remove media components

• Fix cells with 4% paraformaldehyde in 0.1% Triton X-100-PBS for 20 minutes at room temperature

• Block with 1% BSA-4% goat serum-PBS for 1 hour (centrifuge sera and antibodies at 10,000g for 5 minutes before use)

• Wash twice with PBS for 5 minutes each

• Incubate with primary anti-SPBC13E7.07 antibody diluted in 1% BSA-PBS for 45 minutes at room temperature

• Wash twice with 0.2% BSA-PBS for 5 minutes each

• Stain with fluorophore-conjugated secondary antibody for 30 minutes

• Wash twice with PBS for 5 minutes each

• Mount slides with anti-fading agent

For co-localization studies with nuclear envelope markers like Lem2, consider double immunostaining using differentially labeled secondary antibodies.

How can I effectively use SPBC13E7.07 antibody for co-immunoprecipitation experiments?

For effective co-immunoprecipitation with SPBC13E7.07 antibody:

• Prepare cell extracts in appropriate buffer (e.g., CSK-Tris buffer: 20 mM Tris-HCl pH 8.0, 150 mM NaCl, 3 mM MgCl₂, 300 mM sucrose, 1 mM EDTA, and 0.5% Triton X-100)

• Homogenize cells thoroughly while maintaining protein complexes

• Pre-clear lysate with appropriate control beads

• Incubate cleared lysate with SPBC13E7.07 antibody bound to protein A/G beads or directly conjugated beads

• Wash stringently (at least 5 times) to remove non-specifically bound proteins

• Elute bound proteins with appropriate buffer (specific peptide or low pH glycine buffer)

• Analyze by western blot or mass spectrometry

For investigating interactions with nuclear envelope proteins like Lem2-Bqt4, consider sequential IP (as demonstrated in the Lem2 study) or proximity-based methods like BioID.

What are common challenges in detecting SPBC13E7.07 by immunoblotting and how can they be overcome?

Common Challenges and Solutions:

For optimal blotting results, consider using PVDF membranes for higher protein binding capacity and longer blocking times (2+ hours) for reduced background.

How should I optimize fixation methods for SPBC13E7.07 detection in fission yeast cells?

For optimal fixation of fission yeast cells for SPBC13E7.07 detection:

• Compare multiple fixation methods:

  • 4% paraformaldehyde (PFA) for 20 minutes (standard approach)

  • Methanol fixation (-20°C for 6 minutes) for membrane proteins

  • Combined approach: 3.7% formaldehyde for 10 minutes followed by methanol treatment

• Permeabilization considerations:

  • For nuclear proteins, 0.1% Triton X-100 in fixative or post-fixation

  • For membrane-associated forms, gentler permeabilization with 0.05% saponin

• Extraction testing:

  • Pre-extraction with 0.1% Triton X-100 before fixation may enhance nuclear envelope protein detection

  • CSK buffer extraction can help visualize structural components

• Protocol validation:

  • Always run parallel samples with known nuclear envelope markers (e.g., Lem2-FLAG)

  • Include negative controls lacking primary antibody

How can I implement proximity labeling techniques to study SPBC13E7.07 protein interactions in live cells?

Proximity labeling offers powerful approaches for studying SPBC13E7.07 interactions in their native context:

• BioID approach:

  • Generate SPBC13E7.07-BirA* fusion construct

  • Express in S. pombe supplemented with biotin

  • Extract cells and purify biotinylated proteins

  • Identify interacting proteins by mass spectrometry

  • Compare with controls (BirA* alone, irrelevant protein-BirA*)

• TurboID/miniTurbo system:

  • Offers faster labeling kinetics (10-30 minutes vs. 18-24 hours for BioID)

  • Particularly useful for capturing transient interactions

  • Protocol modifications: lower biotin concentration, shorter labeling time

• APEX2 system:

  • Requires H₂O₂ treatment for activation

  • Very rapid labeling (1 minute)

  • Suitable for temporal studies of SPBC13E7.07 interactions

This approach complements traditional co-IP methods by identifying weak or transient interactions that might be missed in standard pull-down experiments like those used for Lem2 characterization .

What CRISPR-based approaches can be used to study SPBC13E7.07 function in fission yeast?

For CRISPR-based functional studies of SPBC13E7.07:

• Gene disruption strategy:

  • Design sgRNAs targeting exonic regions of SPBC13E7.07

  • Optimize Cas9 expression for S. pombe

  • Include repair templates with selection markers

  • Verify disruption by sequencing and protein detection

• CRISPRi for conditional repression:

  • Generate dCas9-repressor fusions optimized for S. pombe

  • Design sgRNAs targeting the SPBC13E7.07 promoter region

  • Implement inducible expression systems

  • Monitor effects on nuclear envelope organization and other cellular processes

• Knock-in tagging:

  • Create endogenous fluorescent fusions for live-cell imaging

  • Design repair templates with GFP/RFP flanked by homology arms

  • Analyze localization dynamics during cell cycle

  • Compare with Lem2-GFP localization patterns

• Base editing applications:

  • Introduce specific mutations without double-strand breaks

  • Target conserved domains or potential interaction surfaces

  • Assess effects on protein-protein interactions and cellular functions

How does SPBC13E7.07 compare to its homologs in other yeast species, and what implications does this have for antibody cross-reactivity?

Comparative analysis indicates SPBC13E7.07 is a Schizosaccharomyces-specific protein , suggesting limited conservation outside this genus. This has important implications:

• Sequence divergence analysis:

  • Limited sequence homology to proteins in Saccharomyces cerevisiae

  • Higher conservation within Schizosaccharomyces species

  • Possibly part of species-specific nuclear envelope organization

• Cross-reactivity considerations:

  • Antibodies raised against SPBC13E7.07 likely won't recognize proteins in distant yeast species

  • May recognize homologs in closely related Schizosaccharomyces species

  • Useful for distinguishing Schizosaccharomyces in mixed cultures

• Functional implications:

  • May represent specialized nuclear envelope functions in fission yeast

  • Could be involved in unique chromosome organization patterns

  • Potentially interacts with Lem2-Bqt4 complex in species-specific manner

For cross-species studies, researchers should validate antibody specificity in each organism and consider using multiple antibodies targeting different epitopes.

What bioinformatic approaches are most effective for predicting antigenic epitopes in SPBC13E7.07 for antibody design?

For optimal epitope prediction in SPBC13E7.07:

• Integrate multiple prediction algorithms:

  • Combine hydrophilicity (Kyte-Doolittle)

  • Surface accessibility

  • Secondary structure prediction

  • B-cell epitope prediction tools (BepiPred, ABCpred)

  • T-cell epitope mapping for immunization effectiveness

• Structural considerations:

  • Predict protein domains using tools like Pfam, SMART

  • Avoid transmembrane regions

  • Target exposed loops and non-structured regions

  • Consider any available structural data on similar proteins

• Conservation analysis:

  • Identify unique regions specific to SPBC13E7.07

  • Avoid highly conserved domains if species-specificity is desired

  • Consider the Schizosaccharomyces-specific nature of the protein

• Validation approach:

  • Synthesize multiple candidate peptides

  • Test immunogenicity in silico and in vitro

  • Consider carrier protein conjugation strategies

This approach maximizes the likelihood of generating antibodies with high specificity and sensitivity for SPBC13E7.07 detection in research applications.